News

Read Our First Quarter Newsletter

(February, 2018) Read our DI Newsletter (PDF) for updates on:

Registry Contract Renewals
ABMS MOC IV Certification
MIPS Reporting Deadlines
Registry Metric Timeline
Able Health MIPS Demo
Study Participation Opportunity
Patient Safety Registry
DI Spotlight: Trijoon Pradhan

Recent Publication from DI Study Identifies Deep Phenotypes Among Patients with Chronic Kidney Disease

Identifying phenotypic subtypes for chronic kidney disease (CKD) is important for improving risk stratification and providing more targeted therapy. A recent paper reports the results of DI study that found that a large dataset of EHRs can be used to identify deep phenotypes retrospectively. Read the paper and abstract.

DARTNet to facilitate research examining how an individual's genetic makeup and clinical decision support can guide medication choices

(December, 2016) The DARTNet Institute is now participating in a new partnership to support research combining the use of an individual's genetic makeup with that of a unique clinical decision support system to help guide medication choices in primary care settings. DARTNet will capture data for a study from patient medical records and collect patient-reported outcomes through questionnaires.

The partnership includes the American College of Clinical Pharmacy Research Institute and Tabula Rasa HealthCare (TRHC), which provides health care organizations with patient-specific, data-driven technology to optimize medication choices to improve patient outcomes, reduce hospitalizations, lower health care costs, and manage risk. questionnaires.

"DARTNet will provide the ability to use embedded data transfer systems from electronic health records to present detailed patient information to Tabula Rasa HealthCare and back to the treating clinicians - both clinical pharmacists and medical clinicians. DARTNet is excited about working with the ACCP PBRN and Tabula Rasa HealthCare to create a system that will allow other practices to consider this approach to medication prescribing," said Dr. Wilson Pace, Chief Medical Officer for the DARTNet Institute.

Findings of study by the comparative effectiveness research through collaborative electronic reporting group published in Pediatrics, with commentary and media coverage

(November, 2016, Updated February, 2017) A study from DI and the CER² (Comparative Effectiveness Research through Collaborative Electronic Reporting) group, "Diagnosis and Medication Treatment of Pediatric Hypertension: A Retrospective Cohort Study" by Kaelber and colleagues, was published in Pediatrics. A commentary (Hill KD and Li JS. "Childhood Hypertension: An Underappreciated Epidemic?") was also published.

The Philadelphia Inquirer published an article about the findings.

The study was also highlighted by the Eunice Kennedy National Institute of Child Health and Human Development.

The AAP News Research Update featured the story as well.